The Mitochondrial Theory of Aging: What It Claims and What the Evidence Shows

Few ideas in the science of aging have been as influential — or as frequently revised — as the mitochondrial theory of aging. It's the reason "mitochondrial health" shows up on supplement labels and in longevity podcasts. But the theory most people half-remember is a simplified version of something researchers have spent seventy years sharpening. Here's what it actually claims, where it came from, and what the current evidence supports.

What does the mitochondrial theory of aging claim?

At its core, the theory holds that aging is driven in large part by progressive damage to mitochondria. Because mitochondria generate the vast majority of a cell's energy — and generate reactive byproducts while doing so — they're both essential and self-exposing. Over a lifetime, the argument goes, this damage accumulates, energy output falls, and tissues age.

The idea descends from the free-radical theory of aging, proposed by Denham Harman in the 1950s and extended by him into a specifically mitochondrial free-radical theory in the 1970s. A historical review in Neurosignals traces how the theory evolved from "free radicals are harmful" to a more structured account of mitochondrial decline (review).

Why mitochondria, specifically?

Mitochondria are unusual: they carry their own small loop of DNA (mtDNA), separate from the DNA in the cell's nucleus. That mtDNA sits close to where reactive oxygen species are produced and has historically been thought to have less robust repair than nuclear DNA. The hypothesis was that mtDNA accumulates mutations faster, degrading the very machinery that powers the cell — a self-reinforcing loop sometimes called the "vicious cycle."

What evidence supports it?

Mitochondrial dysfunction earned its place as one of the formally recognized hallmarks of aging. The 2023 Hallmarks of Aging framework lists it among the interconnected processes that characterize biological aging across species (review). And a review of the mitochondrial basis of aging and age-related disorders catalogs how declining mitochondrial function tracks with many conditions that become more common with age (review).

The most striking experimental support comes from the "mutator mouse." As described in work dissecting the mtDNA mutator mouse, animals engineered to accumulate mitochondrial DNA mutations faster than normal develop features of premature aging — graying, reduced fertility, and shortened lifespan (PRECLINICAL). That's powerful evidence that mitochondrial DNA damage can drive aging phenotypes.

Where does the theory fall short?

Here's where the simple version breaks down. A notable finding in the mutator mouse was that premature aging occurred largely from the mutations themselves rather than from a surge in free radicals — a result discussed in commentary on mitochondrial DNA and aging (review/commentary). That challenged the original free-radical emphasis.

Several other threads complicate the picture. Reactive oxygen species, once cast purely as villains, are now understood to act as important signaling molecules in normal physiology — and some interventions that raise them modestly appear beneficial (a phenomenon called hormesis). Large trials of antioxidant supplements, which should have slowed aging if free radicals were the whole story, have generally failed to extend healthy lifespan. And aging clearly involves the cell nucleus and many non-mitochondrial processes too.

So is the theory wrong?

Not wrong — incomplete. The modern consensus, reflected across these reviews, is that mitochondrial dysfunction is a genuine and important feature of aging, but it operates within a web of interacting hallmarks rather than as the single root cause. Mitochondria matter; they just aren't the whole story.

What does this mean for everyday life?

The practical lesson is encouraging precisely because it's modest. If mitochondrial quality is one meaningful lever among several, then the habits that support mitochondrial function — regular aerobic and resistance exercise, adequate sleep, not smoking, and a diet rich in whole foods and polyphenols — are reasonable investments in healthy aging. Exercise in particular is one of the most reliable ways to support mitochondrial biogenesis and quality control.

Supplements marketed for "mitochondrial support," including standardized Urolithin A, are studied in this context as a way to support normal cellular housekeeping. It's important to keep expectations grounded: no compound reverses aging or rewrites the mitochondrial theory. These are supports for normal function, not cures. People interested in the cellular-energy angle can read more about how SOMA Urolithin A gummies fit a healthy-aging routine, alongside the lifestyle fundamentals that carry the strongest evidence.

Frequently asked questions

Who came up with the mitochondrial theory of aging?

It grew out of Denham Harman's free-radical theory of aging (1950s), which he later extended into a mitochondrial version in the 1970s. Many researchers have since refined it.

Is the free-radical theory of aging the same thing?

They're closely related. The mitochondrial theory is essentially a more specific version that locates the key damage — and the key source of free radicals — in the mitochondria.

Do antioxidants slow aging?

Despite the theory's early predictions, large human trials of antioxidant supplements have generally not shown extended healthy lifespan. Some reactive species serve useful signaling roles, which is one reason the simple antioxidant hypothesis hasn't held up.

Can I "fix" my mitochondria?

You can't reverse aging, but exercise, sleep, and a whole-food diet are well-supported ways to support mitochondrial function. Think support and maintenance, not repair or reversal.

Does Urolithin A relate to this theory?

Urolithin A is studied for mitophagy — the recycling of damaged mitochondria — which connects to the mitochondrial-quality side of the theory. It is a wellness supplement, not a treatment for aging or any disease.

SOMA Health

Support your cellular health, every day

SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.

Shop SOMA Urolithin A Gummies →